Viewing Study NCT01816035


Ignite Creation Date: 2025-12-24 @ 10:09 PM
Ignite Modification Date: 2025-12-31 @ 3:58 AM
Study NCT ID: NCT01816035
Status: COMPLETED
Last Update Posted: 2017-05-23
First Post: 2013-03-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trastuzumab Emtansine in Treating Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed by Surgery
Sponsor: University of Washington
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HER2/Neu Positive View
None Recurrent Breast Carcinoma View
None Stage IIIB Breast Cancer View
None Stage IIIC Breast Cancer View
None Stage IV Breast Cancer View
Keywords: